Eli Lilly opposes using imports to tackle high drug prices

By Robert King

Published July 24, 2018 2:27pm ET

Eli Lilly opposes using imports to tackle high drug prices — FILE - In this file photo taken Thursday, Feb. 9, 2012, a pharmacist is seen working in a lab where medicines are being produced at a manufacturing unit on the outskirts of Mumbai, India. India's patent office on Monday march 12, 2012 effectively ended Bayer's monopoly on a patented cancer drug by allowing the manufacturing of a generic copy at a fraction of the price. | (AP Photo/Rafiq Maqbool, File)

Major drug maker Eli Lilly denounced imports from overseas to provide competition for extremely high-priced drugs.

Lilly’s comments on Tuesday during an earnings call comes nearly a week after the Trump administration said it plans to examine using foreign imports to fight high prices. Lilly said the method itself was concerning.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Eli Lilly opposes using imports to tackle high drug prices

Recommended Stories

FDA to explore importing drugs from overseas to lower prices

Trump administration eyes allowing Medicare to negotiate more drug prices

Trump picks fight with drugmakers with last-minute drug pricing rules

Full midterm coverage.Deeper analysis.

Tag: